Search by Drug Name or NDC
NDC 69784-0420-12 LOVAZA 1 g/1 Details
LOVAZA 1 g/1
LOVAZA is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Woodward Pharma Services LLC. The primary component is OMEGA-3-ACID ETHYL ESTERS.
MedlinePlus Drug Summary
Omega-3 fatty acids are used together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount of triglycerides (a fat-like substance) in the blood in people with very high triglycerides. Omega-3 fatty acids are in a class of medications called antilipemic or lipid-regulating agents. Omega-3 fatty acids may work by decreasing the amount of triglycerides and other fats made in the liver.
Related Packages: 69784-0420-12Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Omega-3 Fatty Acids
Product Information
| NDC | 69784-0420 |
|---|---|
| Product ID | 69784-420_de927620-9977-4b52-9807-61fd73df8a20 |
| Associated GPIs | 39500045200130 |
| GCN Sequence Number | 058486 |
| GCN Sequence Number Description | omega-3 acid ethyl esters CAPSULE 1 G ORAL |
| HIC3 | M4E |
| HIC3 Description | LIPOTROPICS |
| GCN | 23929 |
| HICL Sequence Number | 026793 |
| HICL Sequence Number Description | OMEGA-3 ACID ETHYL ESTERS |
| Brand/Generic | Brand |
| Proprietary Name | LOVAZA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Omega-3-Acid Ethyl Esters |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/1 |
| Substance Name | OMEGA-3-ACID ETHYL ESTERS |
| Labeler Name | Woodward Pharma Services LLC |
| Pharmaceutical Class | Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204940 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69784-0420-12 (69784042012)
| NDC Package Code | 69784-420-12 |
|---|---|
| Billing NDC | 69784042012 |
| Package | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (69784-420-12) |
| Marketing Start Date | 2015-11-30 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 7.49158 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | LOVAZA 1 GM CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 6 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis